Human sirtuin 2 inhibitors, their mechanisms and binding modes (2023)
- Authors:
- USP affiliated authors: EMERY, FLAVIO DA SILVA - FCFRP ; TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; PENTEADO, ANDRÉ BERNDT - FCF ; HASSANIE, HAIFA - FCF
- Unidades: FCFRP; FCF
- DOI: 10.4155/fmc-2022-0253
- Subjects: METABOLISMO; PLANEJAMENTO DE FÁRMACOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Future Medicinal Chemistry
- ISSN: 1756-8919
- Volume/Número/Paginação/Ano: v. 15, n. 3, p. 291-311, 2023
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PENTEADO, André Berndt et al. Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, v. 15, n. 3, p. 291-311, 2023Tradução . . Disponível em: https://doi.org/10.4155/fmc-2022-0253. Acesso em: 10 fev. 2026. -
APA
Penteado, A. B., Hassanie, H., Gomes, R. A., Emery, F. da S., & Trossini, G. H. G. (2023). Human sirtuin 2 inhibitors, their mechanisms and binding modes. Future Medicinal Chemistry, 15( 3), 291-311. doi:10.4155/fmc-2022-0253 -
NLM
Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2026 fev. 10 ] Available from: https://doi.org/10.4155/fmc-2022-0253 -
Vancouver
Penteado AB, Hassanie H, Gomes RA, Emery F da S, Trossini GHG. Human sirtuin 2 inhibitors, their mechanisms and binding modes [Internet]. Future Medicinal Chemistry. 2023 ; 15( 3): 291-311.[citado 2026 fev. 10 ] Available from: https://doi.org/10.4155/fmc-2022-0253 - SETDB1: an emerging target for anticancer drug development [Editorial]
- Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
- Molecular modeling and structural comparison of Leishmania sirtuin 2 enzymes, an epigenetic target in drug discovery
- SETDB1 as a cancer target: challenges and perspectives in drug design
- Synthesis of two 'heteroaromatic rings of the future' for applications in medicinal chemistry
- Synthesis and docking study for compounds analogs of LSD1 inhibitor
- Virtual screening applied in hit identification as LSD1 inhibitors, a epigenetic target for cancer treatment
- Construction and validation of the 3D-structure of T. Cruzi sirtuin-2 by modeling threading
- QSAR studies on the human sirtuin 2 inhibition by non-covalent 7,5,2-anilinobenzamide derivatives
- Docking studies of the Cannabinoids derivatives in O- GlcNAc Transferase (OGT) as anti-cancer candidates
Informações sobre o DOI: 10.4155/fmc-2022-0253 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
